Top news of the week: 09.03.2022.
Companies And Industries
Cancer Immunotherapy Market Expected to Exceed $34B by 2030
A new market research report by InsightAce Analytic projects the immuno-oncology or cancer immunotherapy market will hit $34.69 billion by 2030.
Bioprocess International US West
KBI Biopharma, Inc. will be at BioProcess International US West in San Diego, CA. Be sure to stop by Booth 224 to chat!
Biopharma financings cut by a third, transactions track with 2019 and earlier
Financings in the first two months of 2022 amount to only a third of the money raised during the same timeframe of 2021, and the number of transactions is down by 56%.
Purespring Positive About Prospects Despite Burst Biotech Bubble
<p>Some investors are shying away from early-stage gene therapy companies, but Richard Francis, CEO of kidney disease specialist Purespring, told <em>Scrip</em> that the pharmaceutical ...
Ocugen Ends Week on Low as FDA Rejects Covaxin EUA for Kids
The FDA turned down Ocugen’s Emergency Use Authorization request for Covaxin in children 2 to 18, which the company is co-developing with India’s Bharat Biotech.
One-Step ADC Linker Approach Bypasses Antibody Engineering
Peptide linkers between payloads and antibodies can ensure solubility, prevent early payload loss, and preserve antibody properties
New therapeutic strategy turns a cancer’s advantage into its downfall
Researchers at Fred Hutch and Memorial Sloan Kettering teamed up to develop a cancer treatment strategy that turns a tumor-cell advantage into a disadvantage. The team used their approach ...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the pharma industry reacts to the Ukraine situation; a guide to targeted protein degradation; Janssen/Legend’s US pricing and launch ...